Poziotinib treatment in intractable NSCLC: Epidermal growth factor receptor and human epidermal growth factor receptor 2 exon 20 insertion mutation disease
2016 ◽
Vol 13
(02)
◽
2007 ◽
Vol 97
(6)
◽
pp. 741-744
◽
1984 ◽
Vol 259
(18)
◽
pp. 11534-11542